Trigg Leslie 4
Research Summary
AI-generated summary
Outset Medical (OM) CEO Trigg Leslie Sells 13,914 Shares
What Happened
Trigg Leslie, Chair and CEO of Outset Medical (OM), sold a total of 13,914 shares in two open-market transactions for aggregate proceeds of approximately $71,091. The filings show 11,794 shares sold on 2026-01-20 at $5.12 ($60,385) and 2,120 shares sold on 2026-01-21 at $5.05 ($10,706). The transaction is reported as a sale and the filing’s footnote states these were "sell to cover" shares sold to satisfy partial tax withholding tied to the vesting of 32,552 RSUs granted on June 10, 2025, and therefore not a discretionary sale.
Key Details
- Transaction dates/prices: 2026-01-20 — 11,794 shares @ $5.12; 2026-01-21 — 2,120 shares @ $5.05.
- Aggregate proceeds: ~$71,091.
- Transaction codes: S (Sale); footnote F1: sell-to-cover for tax withholding related to RSU vesting.
- Shares owned after transaction: not disclosed in the provided filing excerpt.
- Filing date: 2026-01-21 (appears timely based on reported transaction dates).
Context
This was a routine sell-to-cover to meet tax withholding obligations from RSU vesting, not an informed discretionary sale by the CEO. Such tax-related sales are common and generally carry less informational weight than open-market purchases.